Regeneron Shares Fall Following BMO's Note Of Roche Preference
June 20, 2014 at 12:14 PM EDT
Shares of Regeneron Pharmaceuticals (NASDAQ: REGN) are down three percent following BMO analyst Jim Birchenough's note of customers ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.